Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Return on Equity (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Return on Equity data on record, last reported at 1.52% in Q3 2025.

  • For Q3 2025, Return on Equity rose 346.0% year-over-year to 1.52%; the TTM value through Sep 2025 reached 1.52%, up 346.0%, while the annual FY2024 figure was 5.18%, 289.0% up from the prior year.
  • Return on Equity reached 1.52% in Q3 2025 per COEP's latest filing, up from 1.73% in the prior quarter.
  • Across five years, Return on Equity topped out at 99.86% in Q1 2024 and bottomed at 19.43% in Q2 2022.
  • Average Return on Equity over 5 years is 1.02%, with a median of 5.84% recorded in 2022.
  • Peak YoY movement for Return on Equity: soared 10980bps in 2024, then crashed -10194bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 8.76% in 2021, then plummeted by -177bps to 6.71% in 2022, then tumbled by -134bps to 15.71% in 2023, then skyrocketed by 83bps to 2.6% in 2024, then skyrocketed by 42bps to 1.52% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 1.52% in Q3 2025, 1.73% in Q2 2025, and 2.08% in Q1 2025.